| 127290737 | CV1157035 | single nucleotide variant | NM_002392.6(MDM2):c.-94A>G | Accelerated tumor formation, susceptibility to [RCV001509968]|not provided [RCV004707634] | benign | 12 | 68808384 | 68808384 | Human | 1 | name |
| 151820939 | CV1425541 | single nucleotide variant | NM_002392.6(MDM2):c.14+3A>G | Accelerated tumor formation, susceptibility to [RCV001954751] | uncertain significance | 12 | 68808494 | 68808494 | Human | 1 | name |
| 151890838 | CV1473124 | single nucleotide variant | NM_002392.6(MDM2):c.15-2A>G | Accelerated tumor formation, susceptibility to [RCV001888518] | uncertain significance | 12 | 68809206 | 68809206 | Human | 1 | name |
| 152145768 | CV1582714 | deletion | NM_002392.6(MDM2):c.15-9del | Accelerated tumor formation, susceptibility to [RCV002201216] | benign | 12 | 68809192 | 68809192 | Human | 1 | name |
| 152171908 | CV1598879 | duplication | NM_002392.6(MDM2):c.15-9dup | Accelerated tumor formation, susceptibility to [RCV002143594] | benign | 12 | 68809191 | 68809192 | Human | 1 | name |
| 156190927 | CV1892868 | single nucleotide variant | NM_002392.6(MDM2):c.99+8T>C | Accelerated tumor formation, susceptibility to [RCV003083868] | likely benign | 12 | 68809300 | 68809300 | Human | 1 | name |
| 156020641 | CV2109534 | single nucleotide variant | NM_002392.6(MDM2):c.14+5T>G | Accelerated tumor formation, susceptibility to [RCV002923045] | uncertain significance | 12 | 68808496 | 68808496 | Human | 1 | name |
| 127286620 | CV1143718 | single nucleotide variant | NM_002392.6(MDM2):c.175-7A>G | Accelerated tumor formation, susceptibility to [RCV001494474] | likely benign | 12 | 68816805 | 68816805 | Human | 1 | name |
| 151864193 | CV1361133 | single nucleotide variant | NM_002392.6(MDM2):c.523+5A>G | Accelerated tumor formation, susceptibility to [RCV001905692]|Accelerated tumor formation, susceptibility to [RCV005006156] | uncertain significance | 12 | 68824656 | 68824656 | Human | 1 | name |
| 152036953 | CV1521818 | deletion | NM_002392.6(MDM2):c.99+13del | Accelerated tumor formation, susceptibility to [RCV002187662] | likely benign | 12 | 68809305 | 68809305 | Human | 1 | name |
| 152108943 | CV1623538 | single nucleotide variant | NM_002392.6(MDM2):c.309-5A>C | Accelerated tumor formation, susceptibility to [RCV002215209] | likely benign | 12 | 68820320 | 68820320 | Human | 1 | name |
| 152036829 | CV1646063 | single nucleotide variant | NM_002392.6(MDM2):c.524-8A>G | Accelerated tumor formation, susceptibility to [RCV002205727] | likely benign | 12 | 68828763 | 68828763 | Human | 1 | name |
| 156367940 | CV1904864 | single nucleotide variant | NM_002392.6(MDM2):c.99+17C>T | Accelerated tumor formation, susceptibility to [RCV002582205] | likely benign | 12 | 68809309 | 68809309 | Human | 1 | name |
| 156212622 | CV2038811 | deletion | NM_002392.6(MDM2):c.99+12del | Accelerated tumor formation, susceptibility to [RCV002766660] | benign | 12 | 68809300 | 68809300 | Human | 1 | name |
| 156008770 | CV2038812 | single nucleotide variant | NM_002392.6(MDM2):c.99+14T>G | Accelerated tumor formation, susceptibility to [RCV002794983] | likely benign | 12 | 68809306 | 68809306 | Human | 1 | name |
| 156139278 | CV2094431 | single nucleotide variant | NM_002392.6(MDM2):c.359-4T>G | Accelerated tumor formation, susceptibility to [RCV002890240] | likely benign | 12 | 68824359 | 68824359 | Human | 1 | name |
| 156112467 | CV2117368 | duplication | NM_002392.6(MDM2):c.840+6dup | Accelerated tumor formation, susceptibility to [RCV002953174] | likely benign | 12 | 68835989 | 68835990 | Human | 1 | name |
| 405045450 | CV2997534 | single nucleotide variant | NM_002392.6(MDM2):c.524-2A>G | Accelerated tumor formation, susceptibility to [RCV003630764] | uncertain significance | 12 | 68828769 | 68828769 | Human | 1 | name |
| 405047001 | CV3012878 | single nucleotide variant | NM_002392.6(MDM2):c.309-5A>G | Accelerated tumor formation, susceptibility to [RCV003630856] | likely benign | 12 | 68820320 | 68820320 | Human | 1 | name |
| 402515503 | CV3062802 | single nucleotide variant | NM_002392.6(MDM2):c.15-11T>C | Accelerated tumor formation, susceptibility to [RCV003629810] | likely benign | 12 | 68809197 | 68809197 | Human | 1 | name |
| 405094589 | CV3134732 | single nucleotide variant | NM_002392.6(MDM2):c.100-5T>G | Accelerated tumor formation, susceptibility to [RCV003835078] | likely benign | 12 | 68813549 | 68813549 | Human | 1 | name |
| 405179625 | CV3147387 | deletion | NM_002392.6(MDM2):c.685-3del | Accelerated tumor formation, susceptibility to [RCV003842289] | benign | 12 | 68835823 | 68835823 | Human | 1 | name |
| 597727264 | CV3707287 | single nucleotide variant | NM_002392.6(MDM2):c.14+19G>A | Accelerated tumor formation, susceptibility to [RCV005011565] | uncertain significance | 12 | 68808510 | 68808510 | Human | 1 | name |
| 15115643 | CV685383 | single nucleotide variant | NM_002392.6(MDM2):c.14+55C>T | Accelerated tumor formation, susceptibility to [RCV001520940]|not provided [RCV004705792] | benign|likely benign | 12 | 68808546 | 68808546 | Human | 1 | name |
| 15147859 | CV690051 | single nucleotide variant | NM_002392.6(MDM2):c.524-3C>T | Accelerated tumor formation, susceptibility to [RCV001400522] | likely benign | 12 | 68828768 | 68828768 | Human | 1 | name |
| 127310567 | CV1157036 | single nucleotide variant | NM_002392.6(MDM2):c.14+285G>C | Accelerated tumor formation, susceptibility to [RCV001518321] | benign | 12 | 68808776 | 68808776 | Human | 1 | name |
| 152111768 | CV1520462 | single nucleotide variant | NM_002392.6(MDM2):c.175-13A>G | Accelerated tumor formation, susceptibility to [RCV002196868] | likely benign | 12 | 68816799 | 68816799 | Human | 1 | name |
| 152089673 | CV1563135 | single nucleotide variant | NM_002392.6(MDM2):c.919-11T>C | Accelerated tumor formation, susceptibility to [RCV002113901] | likely benign | 12 | 68839263 | 68839263 | Human | 1 | name |
| 152060563 | CV1597078 | deletion | NM_002392.6(MDM2):c.840+14del | Accelerated tumor formation, susceptibility to [RCV002208603] | benign | 12 | 68835991 | 68835991 | Human | 1 | name |
| 152121117 | CV1662144 | single nucleotide variant | NM_002392.6(MDM2):c.918+15A>T | Accelerated tumor formation, susceptibility to [RCV002117864] | benign | 12 | 68836764 | 68836764 | Human | 1 | name |
| 152119046 | CV1664663 | single nucleotide variant | NM_002392.6(MDM2):c.359-15T>C | Accelerated tumor formation, susceptibility to [RCV002117601] | likely benign | 12 | 68824348 | 68824348 | Human | 1 | name |
| 155948375 | CV1869144 | single nucleotide variant | NM_002392.6(MDM2):c.684+19G>A | Accelerated tumor formation, susceptibility to [RCV003073995] | likely benign | 12 | 68828950 | 68828950 | Human | 1 | name |
| 156349466 | CV1978164 | single nucleotide variant | NM_002392.6(MDM2):c.684+20T>C | Accelerated tumor formation, susceptibility to [RCV002601719] | likely benign | 12 | 68828951 | 68828951 | Human | 1 | name |
| 155907931 | CV1979887 | single nucleotide variant | NM_002392.6(MDM2):c.174+18A>G | Accelerated tumor formation, susceptibility to [RCV002613782] | uncertain significance | 12 | 68813646 | 68813646 | Human | 1 | name |
| 156251066 | CV2082595 | single nucleotide variant | NM_002392.6(MDM2):c.841-16G>T | Accelerated tumor formation, susceptibility to [RCV002876942] | likely benign | 12 | 68836656 | 68836656 | Human | 1 | name |
| 156161147 | CV2095220 | single nucleotide variant | NM_002392.6(MDM2):c.175-15A>T | Accelerated tumor formation, susceptibility to [RCV002891000] | likely benign | 12 | 68816797 | 68816797 | Human | 1 | name |
| 405001785 | CV2869622 | single nucleotide variant | NM_002392.6(MDM2):c.685-20A>T | Accelerated tumor formation, susceptibility to [RCV003513932] | likely benign | 12 | 68835809 | 68835809 | Human | 1 | name |
| 405001793 | CV2869623 | single nucleotide variant | NM_002392.6(MDM2):c.685-18A>T | Accelerated tumor formation, susceptibility to [RCV003513933] | likely benign | 12 | 68835811 | 68835811 | Human | 1 | name |
| 8599599 | CV28943 | single nucleotide variant | NM_002392.6(MDM2):c.14+309T>G | Accelerated tumor formation, susceptibility to [RCV000014918]|not provided [RCV004707852] | risk factor|benign | 12 | 68808800 | 68808800 | Human | 1 | name |
| 405045436 | CV2997533 | single nucleotide variant | NM_002392.6(MDM2):c.524-18T>G | Accelerated tumor formation, susceptibility to [RCV003630763] | likely benign | 12 | 68828753 | 68828753 | Human | 1 | name |
| 405046367 | CV3008221 | single nucleotide variant | NM_002392.6(MDM2):c.175-18A>G | Accelerated tumor formation, susceptibility to [RCV003630806] | likely benign | 12 | 68816794 | 68816794 | Human | 1 | name |
| 405220171 | CV3157725 | single nucleotide variant | NM_002392.6(MDM2):c.840+14T>C | Accelerated tumor formation, susceptibility to [RCV003863417] | likely benign | 12 | 68835998 | 68835998 | Human | 1 | name |
| 13497401 | CV462454 | single nucleotide variant | NM_002392.6(MDM2):c.100-10C>A | Accelerated tumor formation, susceptibility to [RCV000538596]|not provided [RCV004708941] | benign | 12 | 68813544 | 68813544 | Human | 1 | name |
| 156320295 | CV2111958 | microsatellite | NM_002392.6(MDM2):c.359-8TC[2] | Accelerated tumor formation, susceptibility to [RCV002937705] | likely benign | 12 | 68824355 | 68824356 | Human | | name |
| 152082747 | CV1525206 | deletion | NM_002392.6(MDM2):c.99+7_99+14del | Accelerated tumor formation, susceptibility to [RCV002131030] | likely benign | 12 | 68809297 | 68809304 | Human | 1 | name |
| 127269200 | CV1079616 | single nucleotide variant | NM_002392.6(MDM2):c.264A>G (p.Leu88=) | Accelerated tumor formation, susceptibility to [RCV001404590] | likely benign | 12 | 68816901 | 68816901 | Human | 1 | name |
| 152164041 | CV1543415 | single nucleotide variant | NM_002392.6(MDM2):c.243A>G (p.Val81=) | Accelerated tumor formation, susceptibility to [RCV002123721] | likely benign | 12 | 68816880 | 68816880 | Human | 1 | name |
| 152154861 | CV1560867 | single nucleotide variant | NM_002392.6(MDM2):c.162T>C (p.Tyr54=) | Accelerated tumor formation, susceptibility to [RCV002102792] | likely benign | 12 | 68813616 | 68813616 | Human | 1 | name |
| 156413432 | CV1887913 | single nucleotide variant | NM_002392.6(MDM2):c.234A>G (p.Gln78=) | Accelerated tumor formation, susceptibility to [RCV003073288] | likely benign | 12 | 68816871 | 68816871 | Human | 1 | name |
| 405024682 | CV2890517 | single nucleotide variant | NM_002392.6(MDM2):c.156C>T (p.Asp52=) | Accelerated tumor formation, susceptibility to [RCV003516259] | likely benign | 12 | 68813610 | 68813610 | Human | 1 | name |
| 405047481 | CV3006257 | single nucleotide variant | NM_002392.6(MDM2):c.279C>T (p.Gly93=) | Accelerated tumor formation, susceptibility to [RCV003630893] | likely benign | 12 | 68816916 | 68816916 | Human | 1 | name |
| 597955329 | CV3796206 | single nucleotide variant | NM_002392.6(MDM2):c.114A>G (p.Pro38=) | Accelerated tumor formation, susceptibility to [RCV005137023] | likely benign | 12 | 68813568 | 68813568 | Human | 1 | name |
| 127237511 | CV1101373 | single nucleotide variant | NM_002392.6(MDM2):c.450A>G (p.Glu150=) | Accelerated tumor formation, susceptibility to [RCV001433550] | likely benign | 12 | 68824578 | 68824578 | Human | 1 | name |
| 127290861 | CV1122857 | single nucleotide variant | NM_002392.6(MDM2):c.366G>A (p.Ser122=) | Accelerated tumor formation, susceptibility to [RCV001475884] | likely benign | 12 | 68824370 | 68824370 | Human | 1 | name |
| 127288691 | CV1122858 | single nucleotide variant | NM_002392.6(MDM2):c.777T>C (p.Ser259=) | Accelerated tumor formation, susceptibility to [RCV001450569] | likely benign | 12 | 68835921 | 68835921 | Human | 1 | name |
| 127307797 | CV1122859 | single nucleotide variant | NM_002392.6(MDM2):c.960C>G (p.Pro320=) | Accelerated tumor formation, susceptibility to [RCV001455869] | likely benign | 12 | 68839315 | 68839315 | Human | 1 | name |
| 127292892 | CV1143719 | single nucleotide variant | NM_002392.6(MDM2):c.447G>A (p.Gln149=) | Accelerated tumor formation, susceptibility to [RCV001496590] | likely benign | 12 | 68824575 | 68824575 | Human | 1 | name |
| 127304431 | CV1143720 | single nucleotide variant | NM_002392.6(MDM2):c.724T>C (p.Leu242=) | Accelerated tumor formation, susceptibility to [RCV001479493] | likely benign | 12 | 68835868 | 68835868 | Human | 1 | name |
| 151750844 | CV1360922 | single nucleotide variant | NM_002392.6(MDM2):c.91G>C (p.Glu31Gln) | Accelerated tumor formation, susceptibility to [RCV001894316]|not specified [RCV004641713] | uncertain significance | 12 | 68809284 | 68809284 | Human | 1 | name |
| 151752484 | CV1370660 | single nucleotide variant | NM_002392.6(MDM2):c.85G>A (p.Glu29Lys) | Accelerated tumor formation, susceptibility to [RCV001894478] | uncertain significance | 12 | 68809278 | 68809278 | Human | 1 | name |
| 151831764 | CV1377948 | single nucleotide variant | NM_002392.6(MDM2):c.46A>G (p.Thr16Ala) | Accelerated tumor formation, susceptibility to [RCV002014376] | uncertain significance | 12 | 68809239 | 68809239 | Human | 1 | name |
| 152049733 | CV1602556 | single nucleotide variant | NM_002392.6(MDM2):c.816A>G (p.Gln272=) | Accelerated tumor formation, susceptibility to [RCV002127091] | likely benign | 12 | 68835960 | 68835960 | Human | 1 | name |
| 156158286 | CV1906701 | single nucleotide variant | NM_002392.6(MDM2):c.615G>C (p.Leu205=) | Accelerated tumor formation, susceptibility to [RCV003082790] | likely benign | 12 | 68828862 | 68828862 | Human | 1 | name |
| 156191033 | CV1974410 | single nucleotide variant | NM_002392.6(MDM2):c.393C>T (p.Asn131=) | Accelerated tumor formation, susceptibility to [RCV002625420] | likely benign | 12 | 68824397 | 68824397 | Human | 1 | name |
| 155907110 | CV2130857 | single nucleotide variant | NM_002392.6(MDM2):c.372A>G (p.Ser124=) | Accelerated tumor formation, susceptibility to [RCV002967779] | likely benign | 12 | 68824376 | 68824376 | Human | 1 | name |
| 156367393 | CV2190352 | single nucleotide variant | NM_002392.6(MDM2):c.88C>A (p.Gln30Lys) | Accelerated tumor formation, susceptibility to [RCV003066042] | uncertain significance | 12 | 68809281 | 68809281 | Human | 1 | name |
| 405017291 | CV2867037 | single nucleotide variant | NM_002392.6(MDM2):c.792T>C (p.Asp264=) | Accelerated tumor formation, susceptibility to [RCV003515551] | likely benign | 12 | 68835936 | 68835936 | Human | 1 | name |
| 405018985 | CV2868177 | single nucleotide variant | NM_002392.6(MDM2):c.864G>A (p.Gln288=) | Accelerated tumor formation, susceptibility to [RCV003515708] | likely benign | 12 | 68836695 | 68836695 | Human | 1 | name |
| 405012304 | CV2914108 | single nucleotide variant | NM_002392.6(MDM2):c.858G>T (p.Val286=) | Accelerated tumor formation, susceptibility to [RCV003515081] | likely benign | 12 | 68836689 | 68836689 | Human | 1 | name |
| 402509669 | CV2936393 | single nucleotide variant | NM_002392.6(MDM2):c.783C>T (p.Asp261=) | Accelerated tumor formation, susceptibility to [RCV003629300] | likely benign | 12 | 68835927 | 68835927 | Human | 1 | name |
| 402511937 | CV2953385 | single nucleotide variant | NM_002392.6(MDM2):c.672G>A (p.Thr224=) | Accelerated tumor formation, susceptibility to [RCV003629487] | likely benign | 12 | 68828919 | 68828919 | Human | 1 | name |
| 405043927 | CV2998890 | single nucleotide variant | NM_002392.6(MDM2):c.56C>T (p.Ala19Val) | Accelerated tumor formation, susceptibility to [RCV003630629]|not specified [RCV004371758] | uncertain significance | 12 | 68809249 | 68809249 | Human | 1 | name |
| 402514785 | CV3069247 | single nucleotide variant | NM_002392.6(MDM2):c.50A>G (p.Asp17Gly) | Accelerated tumor formation, susceptibility to [RCV003629745] | uncertain significance | 12 | 68809243 | 68809243 | Human | 1 | name |
| 597727274 | CV3707288 | single nucleotide variant | NM_002392.6(MDM2):c.28A>C (p.Thr10Pro) | Accelerated tumor formation, susceptibility to [RCV005011566] | uncertain significance | 12 | 68809221 | 68809221 | Human | 1 | name |
| 597671809 | CV3707289 | single nucleotide variant | NM_002392.6(MDM2):c.74T>C (p.Ile25Thr) | Accelerated tumor formation, susceptibility to [RCV005004987] | uncertain significance | 12 | 68809267 | 68809267 | Human | 1 | name |
| 597888163 | CV3739224 | single nucleotide variant | NM_002392.6(MDM2):c.32A>G (p.Asn11Ser) | Accelerated tumor formation, susceptibility to [RCV005070771] | uncertain significance | 12 | 68809225 | 68809225 | Human | 1 | name |
| 597868881 | CV3803399 | single nucleotide variant | NM_002392.6(MDM2):c.80C>T (p.Ala27Val) | Accelerated tumor formation, susceptibility to [RCV005147996] | uncertain significance | 12 | 68809273 | 68809273 | Human | 1 | name |
| 597831998 | CV3830882 | single nucleotide variant | NM_002392.6(MDM2):c.780C>T (p.Leu260=) | Accelerated tumor formation, susceptibility to [RCV005170280] | likely benign | 12 | 68835924 | 68835924 | Human | 1 | name |
| 597938444 | CV3852807 | single nucleotide variant | NM_002392.6(MDM2):c.378A>C (p.Thr126=) | Accelerated tumor formation, susceptibility to [RCV005187207] | likely benign | 12 | 68824382 | 68824382 | Human | 1 | name |
| 13485757 | CV463311 | single nucleotide variant | NM_002392.6(MDM2):c.607C>T (p.Leu203=) | Accelerated tumor formation, susceptibility to [RCV000553365]|MDM2-related condition [RCV004758705]|not provided [RCV004707335] | benign | 12 | 68828854 | 68828854 | Human | 2 | name , trait |
| 26922386 | CV840232 | single nucleotide variant | NM_002392.6(MDM2):c.44C>T (p.Pro15Leu) | Accelerated tumor formation, susceptibility to [RCV001061986]|Accelerated tumor formation, susceptibility to [RCV005005022]|Lessel-kubisch syndrome [RCV005394707] | uncertain significance | 12 | 68809237 | 68809237 | Human | 2 | name |
| 38464623 | CV956924 | single nucleotide variant | NM_002392.6(MDM2):c.309G>A (p.Arg103=) | Accelerated tumor formation, susceptibility to [RCV001247427] | uncertain significance | 12 | 68820325 | 68820325 | Human | 1 | name |
| 38492106 | CV956925 | single nucleotide variant | NM_002392.6(MDM2):c.918T>C (p.Ala306=) | Accelerated tumor formation, susceptibility to [RCV001239900] | uncertain significance | 12 | 68836749 | 68836749 | Human | 1 | name |
| 127331270 | CV1122860 | single nucleotide variant | NM_002392.6(MDM2):c.1002T>C (p.Asn334=) | Accelerated tumor formation, susceptibility to [RCV001471422] | likely benign | 12 | 68839357 | 68839357 | Human | 1 | name |
| 127307706 | CV1157037 | single nucleotide variant | NM_002392.6(MDM2):c.1080A>G (p.Glu360=) | Accelerated tumor formation, susceptibility to [RCV001517224]|not provided [RCV004709054] | benign | 12 | 68839435 | 68839435 | Human | 1 | name |
| 151766931 | CV1348659 | single nucleotide variant | NM_002392.6(MDM2):c.185A>T (p.Tyr62Phe) | Accelerated tumor formation, susceptibility to [RCV001895953] | uncertain significance | 12 | 68816822 | 68816822 | Human | 1 | name |
| 151858486 | CV1398306 | single nucleotide variant | NM_002392.6(MDM2):c.212G>A (p.Arg71Gln) | Accelerated tumor formation, susceptibility to [RCV002017467] | uncertain significance | 12 | 68816849 | 68816849 | Human | 1 | name |
| 151806917 | CV1487098 | single nucleotide variant | NM_002392.6(MDM2):c.154G>C (p.Asp52His) | Accelerated tumor formation, susceptibility to [RCV001918232] | uncertain significance | 12 | 68813608 | 68813608 | Human | 1 | name |
| 151749448 | CV1487561 | single nucleotide variant | NM_002392.6(MDM2):c.226A>C (p.Lys76Gln) | Accelerated tumor formation, susceptibility to [RCV001947987] | uncertain significance | 12 | 68816863 | 68816863 | Human | 1 | name |
| 152038617 | CV1524204 | single nucleotide variant | NM_002392.6(MDM2):c.1491C>T (p.Pro497=) | Accelerated tumor formation, susceptibility to [RCV002125746] | likely benign | 12 | 68839846 | 68839846 | Human | 1 | name |
| 152151730 | CV1559731 | single nucleotide variant | NM_002392.6(MDM2):c.1365C>T (p.Cys455=) | Accelerated tumor formation, susceptibility to [RCV002220921]|not provided [RCV004704707] | likely benign | 12 | 68839720 | 68839720 | Human | 1 | name |
| 156197339 | CV1885902 | single nucleotide variant | NM_002392.6(MDM2):c.1248T>C (p.Asp416=) | Accelerated tumor formation, susceptibility to [RCV003084086] | likely benign | 12 | 68839603 | 68839603 | Human | 1 | name |
| 156092659 | CV2167136 | single nucleotide variant | NM_002392.6(MDM2):c.1011T>A (p.Pro337=) | Accelerated tumor formation, susceptibility to [RCV003038274] | likely benign | 12 | 68839366 | 68839366 | Human | 1 | name |
| 405005034 | CV2889259 | single nucleotide variant | NM_002392.6(MDM2):c.1485T>C (p.Tyr495=) | Accelerated tumor formation, susceptibility to [RCV003514246] | likely benign | 12 | 68839840 | 68839840 | Human | 1 | name |
| 402503977 | CV3019577 | single nucleotide variant | NM_002392.6(MDM2):c.1179A>G (p.Gln393=) | Accelerated tumor formation, susceptibility to [RCV003628638] | likely benign | 12 | 68839534 | 68839534 | Human | 1 | name |
| 402515269 | CV3062690 | single nucleotide variant | NM_002392.6(MDM2):c.178C>G (p.Leu60Val) | Accelerated tumor formation, susceptibility to [RCV003629790] | uncertain significance | 12 | 68816815 | 68816815 | Human | 1 | name |
| 402513647 | CV3063619 | single nucleotide variant | NM_002392.6(MDM2):c.1368T>C (p.Ile456=) | Accelerated tumor formation, susceptibility to [RCV003629652] | likely benign | 12 | 68839723 | 68839723 | Human | 1 | name |
| 598124239 | CV3881403 | deletion | NM_002392.6(MDM2):c.857del (p.Val286fs) | not specified [RCV005231828] | uncertain significance | 12 | 68836688 | 68836688 | Human | | name |
| 38478123 | CV936244 | single nucleotide variant | NM_002392.6(MDM2):c.1446A>G (p.Pro482=) | Accelerated tumor formation, susceptibility to [RCV001205406] | uncertain significance | 12 | 68839801 | 68839801 | Human | 1 | name |
| 126747634 | CV1010578 | single nucleotide variant | NM_002392.6(MDM2):c.560G>C (p.Arg187Thr) | Accelerated tumor formation, susceptibility to [RCV001326190] | uncertain significance | 12 | 68828807 | 68828807 | Human | 1 | name |
| 126742272 | CV1031100 | single nucleotide variant | NM_002392.6(MDM2):c.350A>G (p.Asn117Ser) | Accelerated tumor formation, susceptibility to [RCV001350990]|not specified [RCV004036641] | uncertain significance | 12 | 68820366 | 68820366 | Human | 1 | name |
| 151807912 | CV1337171 | single nucleotide variant | NM_002392.6(MDM2):c.818A>C (p.Glu273Ala) | Accelerated tumor formation, susceptibility to [RCV002028690]|not specified [RCV004824058] | uncertain significance | 12 | 68835962 | 68835962 | Human | 1 | name |
| 151863542 | CV1347944 | single nucleotide variant | NM_002392.6(MDM2):c.913T>G (p.Leu305Val) | Accelerated tumor formation, susceptibility to [RCV001959539] | uncertain significance | 12 | 68836744 | 68836744 | Human | 1 | name |
| 151711045 | CV1377311 | single nucleotide variant | NM_002392.6(MDM2):c.971A>T (p.His324Leu) | Accelerated tumor formation, susceptibility to [RCV001889387] | uncertain significance | 12 | 68839326 | 68839326 | Human | 1 | name |
| 151865167 | CV1405979 | single nucleotide variant | NM_002392.6(MDM2):c.365C>T (p.Ser122Leu) | Accelerated tumor formation, susceptibility to [RCV001959738] | uncertain significance | 12 | 68824369 | 68824369 | Human | 1 | name |
| 151770237 | CV1464881 | single nucleotide variant | NM_002392.6(MDM2):c.536A>G (p.Asp179Gly) | Accelerated tumor formation, susceptibility to [RCV002025289] | uncertain significance | 12 | 68828783 | 68828783 | Human | 1 | name |
| 151726644 | CV1488299 | single nucleotide variant | NM_002392.6(MDM2):c.886T>G (p.Ser296Ala) | Accelerated tumor formation, susceptibility to [RCV001966673] | uncertain significance | 12 | 68836717 | 68836717 | Human | 1 | name |
| 151848472 | CV1514275 | single nucleotide variant | NM_002392.6(MDM2):c.948A>C (p.Glu316Asp) | Accelerated tumor formation, susceptibility to [RCV001957654] | uncertain significance | 12 | 68839303 | 68839303 | Human | 1 | name |
| 156308137 | CV1895062 | single nucleotide variant | NM_002392.6(MDM2):c.613C>G (p.Leu205Val) | Accelerated tumor formation, susceptibility to [RCV003088284] | uncertain significance | 12 | 68828860 | 68828860 | Human | 1 | name |
| 156203803 | CV1905751 | single nucleotide variant | NM_002392.6(MDM2):c.431T>C (p.Leu144Pro) | Accelerated tumor formation, susceptibility to [RCV003089923]|not specified [RCV004073126] | likely benign|uncertain significance | 12 | 68824559 | 68824559 | Human | 1 | name |
| 156028435 | CV1914111 | single nucleotide variant | NM_002392.6(MDM2):c.910T>C (p.Ser304Pro) | Accelerated tumor formation, susceptibility to [RCV002619737] | uncertain significance | 12 | 68836741 | 68836741 | Human | 1 | name |
| 155935377 | CV1916383 | single nucleotide variant | NM_002392.6(MDM2):c.421C>G (p.Gln141Glu) | Accelerated tumor formation, susceptibility to [RCV002615264] | uncertain significance | 12 | 68824425 | 68824425 | Human | 1 | name |
| 156404947 | CV1916799 | single nucleotide variant | NM_002392.6(MDM2):c.694G>T (p.Ala232Ser) | Accelerated tumor formation, susceptibility to [RCV002606216] | uncertain significance | 12 | 68835838 | 68835838 | Human | 1 | name |
| 156436125 | CV1937345 | single nucleotide variant | NM_002392.6(MDM2):c.999G>T (p.Glu333Asp) | Accelerated tumor formation, susceptibility to [RCV003105209] | uncertain significance | 12 | 68839354 | 68839354 | Human | 1 | name |
| 156225557 | CV1981574 | single nucleotide variant | NM_002392.6(MDM2):c.589C>T (p.Leu197Phe) | Accelerated tumor formation, susceptibility to [RCV002626604] | uncertain significance | 12 | 68828836 | 68828836 | Human | 1 | name |
| 156114040 | CV1993791 | single nucleotide variant | NM_002392.6(MDM2):c.398G>A (p.Cys133Tyr) | Accelerated tumor formation, susceptibility to [RCV002662600] | uncertain significance | 12 | 68824402 | 68824402 | Human | 1 | name |
| 156095293 | CV2110458 | single nucleotide variant | NM_002392.6(MDM2):c.403C>T (p.Leu135Phe) | Accelerated tumor formation, susceptibility to [RCV002926834] | uncertain significance | 12 | 68824407 | 68824407 | Human | 1 | name |
| 156390948 | CV2118632 | single nucleotide variant | NM_002392.6(MDM2):c.643A>G (p.Arg215Gly) | Accelerated tumor formation, susceptibility to [RCV002943900] | uncertain significance | 12 | 68828890 | 68828890 | Human | 1 | name |
| 155901197 | CV2151512 | single nucleotide variant | NM_002392.6(MDM2):c.385A>C (p.Ser129Arg) | Accelerated tumor formation, susceptibility to [RCV003011639] | uncertain significance | 12 | 68824389 | 68824389 | Human | 1 | name |
| 156330709 | CV2180982 | single nucleotide variant | NM_002392.6(MDM2):c.305A>G (p.His102Arg) | Accelerated tumor formation, susceptibility to [RCV003047192] | uncertain significance | 12 | 68816942 | 68816942 | Human | 1 | name |
| 156297536 | CV2310532 | single nucleotide variant | NM_002392.6(MDM2):c.919G>A (p.Asp307Asn) | not specified [RCV004163554] | uncertain significance | 12 | 68839274 | 68839274 | Human | | name |
| 405002473 | CV2880784 | single nucleotide variant | NM_002392.6(MDM2):c.377C>T (p.Thr126Ile) | Accelerated tumor formation, susceptibility to [RCV003513998] | uncertain significance | 12 | 68824381 | 68824381 | Human | 1 | name |
| 405024790 | CV2890804 | single nucleotide variant | NM_002392.6(MDM2):c.992T>G (p.Leu331Arg) | Accelerated tumor formation, susceptibility to [RCV003516268] | uncertain significance | 12 | 68839347 | 68839347 | Human | 1 | name |
| 405047419 | CV3009636 | single nucleotide variant | NM_002392.6(MDM2):c.980G>C (p.Arg327Thr) | Accelerated tumor formation, susceptibility to [RCV003630888] | uncertain significance | 12 | 68839335 | 68839335 | Human | 1 | name |
| 405046670 | CV3012277 | single nucleotide variant | NM_002392.6(MDM2):c.582T>A (p.Ser194Arg) | Accelerated tumor formation, susceptibility to [RCV003630830] | uncertain significance | 12 | 68828829 | 68828829 | Human | 1 | name |
| 405049181 | CV3021793 | single nucleotide variant | NM_002392.6(MDM2):c.815A>G (p.Gln272Arg) | Accelerated tumor formation, susceptibility to [RCV003631020] | uncertain significance | 12 | 68835959 | 68835959 | Human | 1 | name |
| 402515751 | CV3066611 | single nucleotide variant | NM_002392.6(MDM2):c.443T>C (p.Leu148Pro) | Accelerated tumor formation, susceptibility to [RCV003629829] | uncertain significance | 12 | 68824571 | 68824571 | Human | 1 | name |
| 405254033 | CV3178673 | single nucleotide variant | NM_002392.6(MDM2):c.652A>G (p.Ser218Gly) | Accelerated tumor formation, susceptibility to [RCV003871275] | uncertain significance | 12 | 68828899 | 68828899 | Human | 1 | name |
| 405680163 | CV3289111 | single nucleotide variant | NM_002392.6(MDM2):c.865G>A (p.Ala289Thr) | Accelerated tumor formation, susceptibility to [RCV005006389]|Accelerated tumor formation, susceptibility to [RCV005104542]|not specified [RCV004421472] | uncertain significance | 12 | 68836696 | 68836696 | Human | 1 | name |
| 597658832 | CV3553179 | single nucleotide variant | NM_002392.6(MDM2):c.301G>C (p.Glu101Gln) | not specified [RCV004828098] | uncertain significance | 12 | 68816938 | 68816938 | Human | | name |
| 597658837 | CV3553180 | single nucleotide variant | NM_002392.6(MDM2):c.821T>C (p.Leu274Pro) | not specified [RCV004828099] | uncertain significance | 12 | 68835965 | 68835965 | Human | | name |
| 597658849 | CV3553184 | single nucleotide variant | NM_002392.6(MDM2):c.568C>T (p.His190Tyr) | not specified [RCV004828101] | uncertain significance | 12 | 68828815 | 68828815 | Human | | name |
| 597671818 | CV3707290 | single nucleotide variant | NM_002392.6(MDM2):c.544T>C (p.Ser182Pro) | Accelerated tumor formation, susceptibility to [RCV005004988] | uncertain significance | 12 | 68828791 | 68828791 | Human | 1 | name |
| 597727283 | CV3707291 | single nucleotide variant | NM_002392.6(MDM2):c.598G>A (p.Asp200Asn) | Accelerated tumor formation, susceptibility to [RCV005011567] | uncertain significance | 12 | 68828845 | 68828845 | Human | 1 | name |
| 597910410 | CV3782129 | single nucleotide variant | NM_002392.6(MDM2):c.781G>A (p.Asp261Asn) | Accelerated tumor formation, susceptibility to [RCV005128621] | uncertain significance | 12 | 68835925 | 68835925 | Human | 1 | name |
| 597871171 | CV3835597 | single nucleotide variant | NM_002392.6(MDM2):c.631A>G (p.Ile211Val) | Accelerated tumor formation, susceptibility to [RCV005176588] | uncertain significance | 12 | 68828878 | 68828878 | Human | 1 | name |
| 597935631 | CV3845275 | single nucleotide variant | NM_002392.6(MDM2):c.899A>T (p.Asp300Val) | Accelerated tumor formation, susceptibility to [RCV005186588] | uncertain significance | 12 | 68836730 | 68836730 | Human | 1 | name |
| 597904322 | CV3845982 | single nucleotide variant | NM_002392.6(MDM2):c.625A>G (p.Arg209Gly) | Accelerated tumor formation, susceptibility to [RCV005181604] | uncertain significance | 12 | 68828872 | 68828872 | Human | 1 | name |
| 597951689 | CV3847442 | single nucleotide variant | NM_002392.6(MDM2):c.419A>T (p.Asp140Val) | Accelerated tumor formation, susceptibility to [RCV005190424] | uncertain significance | 12 | 68824423 | 68824423 | Human | 1 | name |
| 598211663 | CV3992920 | single nucleotide variant | NM_002392.6(MDM2):c.533C>T (p.Ser178Leu) | not specified [RCV005378056] | uncertain significance | 12 | 68828780 | 68828780 | Human | | name |
| 13487130 | CV462456 | single nucleotide variant | NM_002392.6(MDM2):c.631A>C (p.Ile211Leu) | Accelerated tumor formation, susceptibility to [RCV000531653]|not specified [RCV004024212] | uncertain significance | 12 | 68828878 | 68828878 | Human | 1 | name |
| 13622513 | CV527341 | single nucleotide variant | NM_002392.6(MDM2):c.565C>T (p.Arg189Cys) | Accelerated tumor formation, susceptibility to [RCV000649880] | uncertain significance | 12 | 68828812 | 68828812 | Human | 1 | name |
| 26915420 | CV840233 | single nucleotide variant | NM_002392.6(MDM2):c.683C>T (p.Pro228Leu) | Accelerated tumor formation, susceptibility to [RCV001055702] | uncertain significance | 12 | 68828930 | 68828930 | Human | 1 | name |
| 26920740 | CV840234 | single nucleotide variant | NM_002392.6(MDM2):c.995G>A (p.Arg332His) | Accelerated tumor formation, susceptibility to [RCV001060294]|Accelerated tumor formation, susceptibility to [RCV005005020] | uncertain significance | 12 | 68839350 | 68839350 | Human | 1 | name |
| 38483598 | CV926723 | single nucleotide variant | NM_002392.6(MDM2):c.955C>A (p.Pro319Thr) | Accelerated tumor formation, susceptibility to [RCV001219017] | uncertain significance | 12 | 68839310 | 68839310 | Human | 1 | name |
| 38457012 | CV936243 | single nucleotide variant | NM_002392.6(MDM2):c.961C>T (p.Leu321Phe) | Accelerated tumor formation, susceptibility to [RCV001211000] | uncertain significance | 12 | 68839316 | 68839316 | Human | 1 | name |
| 126749298 | CV995357 | single nucleotide variant | NM_002392.6(MDM2):c.583A>G (p.Ile195Val) | Accelerated tumor formation, susceptibility to [RCV001297108] | uncertain significance | 12 | 68828830 | 68828830 | Human | 1 | name |
| 126763985 | CV1010579 | single nucleotide variant | NM_002392.6(MDM2):c.1232A>G (p.Tyr411Cys) | Accelerated tumor formation, susceptibility to [RCV001319458]|not specified [RCV004034971] | uncertain significance | 12 | 68839587 | 68839587 | Human | 1 | name |
| 126908770 | CV1048098 | single nucleotide variant | NM_002392.6(MDM2):c.1121A>G (p.Asn374Ser) | Accelerated tumor formation, susceptibility to [RCV001368105] | uncertain significance | 12 | 68839476 | 68839476 | Human | 1 | name |
| 151805844 | CV1340128 | single nucleotide variant | NM_002392.6(MDM2):c.1242A>C (p.Gln414His) | Accelerated tumor formation, susceptibility to [RCV001867545] | uncertain significance | 12 | 68839597 | 68839597 | Human | 1 | name |
| 151860600 | CV1400264 | single nucleotide variant | NM_002392.6(MDM2):c.1289A>T (p.Glu430Val) | Accelerated tumor formation, susceptibility to [RCV001997086] | uncertain significance | 12 | 68839644 | 68839644 | Human | 1 | name |
| 151801432 | CV1449496 | single nucleotide variant | NM_002392.6(MDM2):c.1237A>G (p.Ser413Gly) | Accelerated tumor formation, susceptibility to [RCV002048016] | uncertain significance | 12 | 68839592 | 68839592 | Human | 1 | name |
| 151852470 | CV1459611 | deletion | NM_002392.6(MDM2):c.57_59del (p.Val20del) | Accelerated tumor formation, susceptibility to [RCV002033358] | uncertain significance | 12 | 68809250 | 68809252 | Human | 1 | name |
| 151838063 | CV1469995 | single nucleotide variant | NM_002392.6(MDM2):c.1002T>A (p.Asn334Lys) | Accelerated tumor formation, susceptibility to [RCV001881016] | uncertain significance | 12 | 68839357 | 68839357 | Human | 1 | name |
| 151811742 | CV1506781 | single nucleotide variant | NM_002392.6(MDM2):c.1039A>G (p.Ile347Val) | Accelerated tumor formation, susceptibility to [RCV001918677] | uncertain significance | 12 | 68839394 | 68839394 | Human | 1 | name |
| 151848516 | CV1510431 | single nucleotide variant | NM_002392.6(MDM2):c.1219A>G (p.Ser407Gly) | Accelerated tumor formation, susceptibility to [RCV001957660] | uncertain significance | 12 | 68839574 | 68839574 | Human | 1 | name |
| 156392389 | CV1869601 | single nucleotide variant | NM_002392.6(MDM2):c.1202C>T (p.Ser401Phe) | Accelerated tumor formation, susceptibility to [RCV003051470] | uncertain significance | 12 | 68839557 | 68839557 | Human | 1 | name |
| 156224571 | CV1900046 | single nucleotide variant | NM_002392.6(MDM2):c.1161A>C (p.Lys387Asn) | Accelerated tumor formation, susceptibility to [RCV003085125] | uncertain significance | 12 | 68839516 | 68839516 | Human | 1 | name |
| 156296858 | CV1923324 | single nucleotide variant | NM_002392.6(MDM2):c.1190G>A (p.Ser397Asn) | Accelerated tumor formation, susceptibility to [RCV002647445]|not specified [RCV004070702] | uncertain significance | 12 | 68839545 | 68839545 | Human | 1 | name |
| 156072780 | CV1989144 | single nucleotide variant | NM_002392.6(MDM2):c.1114A>G (p.Ile372Val) | Accelerated tumor formation, susceptibility to [RCV002638650] | uncertain significance | 12 | 68839469 | 68839469 | Human | 1 | name |
| 156025698 | CV2020215 | single nucleotide variant | NM_002392.6(MDM2):c.1301C>G (p.Ser434Cys) | Accelerated tumor formation, susceptibility to [RCV002691215] | uncertain significance | 12 | 68839656 | 68839656 | Human | 1 | name |
| 156376295 | CV2059603 | single nucleotide variant | NM_002392.6(MDM2):c.1079A>G (p.Glu360Gly) | Accelerated tumor formation, susceptibility to [RCV002814719] | uncertain significance | 12 | 68839434 | 68839434 | Human | 1 | name |
| 155942183 | CV2068297 | single nucleotide variant | NM_002392.6(MDM2):c.1030A>G (p.Lys344Glu) | Accelerated tumor formation, susceptibility to [RCV002839484] | uncertain significance | 12 | 68839385 | 68839385 | Human | 1 | name |
| 156326429 | CV2116030 | single nucleotide variant | NM_002392.6(MDM2):c.1304G>A (p.Ser435Asn) | Accelerated tumor formation, susceptibility to [RCV002938109] | uncertain significance | 12 | 68839659 | 68839659 | Human | 1 | name |
| 156353415 | CV2118872 | single nucleotide variant | NM_002392.6(MDM2):c.1191T>G (p.Ser397Arg) | Accelerated tumor formation, susceptibility to [RCV002966470] | uncertain significance | 12 | 68839546 | 68839546 | Human | 1 | name |
| 405019555 | CV2872065 | single nucleotide variant | NM_002392.6(MDM2):c.1150A>T (p.Asn384Tyr) | Accelerated tumor formation, susceptibility to [RCV003515760] | uncertain significance | 12 | 68839505 | 68839505 | Human | 1 | name |
| 405003366 | CV2881162 | single nucleotide variant | NM_002392.6(MDM2):c.1405A>T (p.Thr469Ser) | Accelerated tumor formation, susceptibility to [RCV003514041] | uncertain significance | 12 | 68839760 | 68839760 | Human | 1 | name |
| 405003027 | CV2885308 | single nucleotide variant | NM_002392.6(MDM2):c.1309C>T (p.Pro437Ser) | Accelerated tumor formation, susceptibility to [RCV003514074] | uncertain significance | 12 | 68839664 | 68839664 | Human | 1 | name |
| 402522996 | CV2969836 | single nucleotide variant | NM_002392.6(MDM2):c.1103G>A (p.Cys368Tyr) | Accelerated tumor formation, susceptibility to [RCV003630359] | uncertain significance | 12 | 68839458 | 68839458 | Human | 1 | name |
| 597634203 | CV3553181 | single nucleotide variant | NM_002392.6(MDM2):c.1073A>C (p.Gln358Pro) | not specified [RCV004824112] | uncertain significance | 12 | 68839428 | 68839428 | Human | | name |
| 597727293 | CV3707292 | single nucleotide variant | NM_002392.6(MDM2):c.1151A>G (p.Asn384Ser) | Accelerated tumor formation, susceptibility to [RCV005011568] | uncertain significance | 12 | 68839506 | 68839506 | Human | 1 | name |
| 597867579 | CV3764118 | single nucleotide variant | NM_002392.6(MDM2):c.1022G>A (p.Gly341Glu) | Accelerated tumor formation, susceptibility to [RCV005107115]|not specified [RCV005379718] | uncertain significance | 12 | 68839377 | 68839377 | Human | 1 | name |
| 597948645 | CV3848718 | single nucleotide variant | NM_002392.6(MDM2):c.1061A>G (p.Glu354Gly) | Accelerated tumor formation, susceptibility to [RCV005189655] | uncertain significance | 12 | 68839416 | 68839416 | Human | 1 | name |
| 598211669 | CV3992921 | single nucleotide variant | NM_002392.6(MDM2):c.1267G>C (p.Glu423Gln) | not specified [RCV005378057] | uncertain significance | 12 | 68839622 | 68839622 | Human | | name |
| 15040330 | CV682782 | single nucleotide variant | NM_002392.6(MDM2):c.1492T>C (p.Ter498Gln) | Accelerated tumor formation, susceptibility to [RCV004813145]|Lessel-kubisch syndrome [RCV000856714] | pathogenic|likely pathogenic | 12 | 68839847 | 68839847 | Human | 2 | name |
| 38479318 | CV926724 | single nucleotide variant | NM_002392.6(MDM2):c.1241A>T (p.Gln414Leu) | Accelerated tumor formation, susceptibility to [RCV001217018] | uncertain significance | 12 | 68839596 | 68839596 | Human | 1 | name |
| 38497011 | CV956926 | single nucleotide variant | NM_002392.6(MDM2):c.1202C>G (p.Ser401Cys) | Accelerated tumor formation, susceptibility to [RCV001242918] | uncertain significance | 12 | 68839557 | 68839557 | Human | 1 | name |
| 151806416 | CV1427469 | deletion | NM_002392.6(MDM2):c.698_700del (p.Gly233del) | Accelerated tumor formation, susceptibility to [RCV001899541] | uncertain significance | 12 | 68835840 | 68835842 | Human | 1 | name |
| 402519029 | CV3080902 | deletion | NM_002392.6(MDM2):c.1284_1287del (p.Glu429fs) | Accelerated tumor formation, susceptibility to [RCV003630079] | uncertain significance | 12 | 68839637 | 68839640 | Human | 1 | name |
